NASDAQ : IFRX
InflaRx N.V. — Financial statements
Healthcare · Biotechnology · Germany
Last price 1.715 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 252.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
InflaRx N.V. (IFRX) reported revenue of -10.10K EUR (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | -10.10K | 29.33K | 165.79K | 63.09K | ||
| Cost of Revenue | 4.86M | 7.27M | 3.32M | 532.26K | ||
| Gross Profit | -4.87M | -7.24M | -3.15M | -469.17K | ||
| Selling, General & Admin | 13.01M | 17.96M | 19.78M | 16.63M | 14.87M | 11.98M |
| Research & Development | 20.41M | 25.72M | 35.36M | 41.02M | 37.53M | 35.70M |
| Other Operating Expenses | -2.63M | -2.66M | -5.29M | -60.01K | -20.16M | -47.84K |
| Operating Expenses | 30.78M | 41.02M | 49.86M | 57.59M | 32.24M | 47.63M |
| Operating Income | -35.65M | -48.26M | -53.01M | -58.06M | -32.24M | -47.63M |
| Interest Expense | -61.25K | -39.24K | -20.66K | -35.63K | -45.25K | -24.77K |
| Interest & Investment Income | 1.93M | 1.85M | 3.20M | 3.80M | 608.68K | 109.39K |
| Currency Exchange Gain (Loss) | 3.98M | -4.85M | 3.67M | -1.84M | 2.44M | 1.96M |
| Other Non Operating Income (Expenses) | -8.39M | 5.68M | 103.29K | 313.24K | -252.47K | -44.00K |
| EBT Excluding Unusual Items | -38.19M | -45.62M | -46.06M | -55.82M | -29.48M | -45.63M |
| Other Unusual Items | -942.49K | 13.16M | ||||
| Pretax Income | -39.13M | -45.62M | -46.06M | -42.67M | -29.48M | -45.63M |
| Income Tax Expense | 12.28K | 12.28K | 5.22K | |||
| Net Income | -39.14M | -45.63M | -46.06M | -42.67M | -29.48M | -45.63M |
| Net Income to Common | -39.14M | -45.63M | -46.06M | -42.67M | -29.48M | -45.63M |
| Shares Outstanding (Basic) | 82.07M | 67.29M | 58.92M | 54.94M | 44.21M | 41.63M |
| Shares Outstanding (Diluted) | 82.07M | 67.29M | 58.92M | 54.94M | 44.21M | 41.63M |
| EPS (Basic) | -0.48 | -0.68 | -0.78 | -0.78 | -0.67 | -1.10 |
| EPS (Diluted) | -0.48 | -0.68 | -0.78 | -0.78 | -0.67 | -1.10 |
| Free Cash Flow | -23.85M | -35.43M | -48.60M | -37.89M | -33.91M | -39.97M |
| Free Cash Flow Per Share | -0.29 | -0.53 | -0.82 | -0.69 | -0.77 | -0.96 |
| Operating Margin | -164,533.84% | -31,973.69% | -92,034.02% | |||
| Profit Margin | -155,582.08% | -27,784.96% | -67,630.70% | |||
| Free Cash Flow Margin | -120,793.78% | -29,316.52% | -60,064.46% | |||
| EBITDA | -35.64M | -48.20M | -52.95M | -57.50M | -32.03M | -47.34M |
| D&A For EBITDA | 11.67K | 61.21K | 56.08K | 567.78K | 212.16K | 297.88K |
| EBIT | -35.65M | -48.26M | -53.01M | -58.06M | -32.24M | -47.63M |
Balance sheet
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 146.57M | 16.02M | 18.38M | 12.77M | 16.27M | 26.25M |
| Short-Term Investments | 11.95M | 30.44M | 34.46M | 77.50M | 732.97K | |
| Cash & Short-Term Investments | 158.51M | 46.46M | 52.84M | 90.27M | 17.00M | 26.25M |
| Other Receivables | 1.55M | 1.43M | 1.74M | 3.79M | 1.43M | 1.28M |
| Receivables | 1.55M | 1.43M | 1.74M | 3.79M | 1.43M | 1.28M |
| Inventory | 6.90M | 11.37M | ||||
| Prepaid Expenses | 2.11M | 923.83K | 354.95K | 273.00K | 1.84M | 334.28K |
| Other Current Assets | 3.22M | 4.82M | 9.83M | 3.76M | 77.14M | 67.81M |
| Total Current Assets | 165.40M | 53.63M | 71.66M | 109.47M | 97.41M | 95.68M |
| Property, Plant & Equipment | 1.07M | 1.15M | 1.01M | 1.36M | 1.64M | 1.68M |
| Long-Term Investments | 237.37K | 3.09M | 9.05M | 2.90M | 27.21M | |
| Other Intangible Assets | 78.12K | 30.32K | 7.26K | 42.84K | 138.91K | 235.22K |
| Other Long-Term Assets | 363.22K | 163.13K | 247.75K | 283.25K | 308.07K | 336.57K |
| Total Assets | 166.91M | 55.22M | 76.02M | 120.21M | 102.40M | 125.14M |
| Accounts Payable | 832.88K | 972.38K | 3.41M | 5.10M | 1.57M | 1.69M |
| Accrued Expenses | 5.38M | 5.59M | 10.05M | 8.48M | 4.73M | 8.27M |
| Current Portion of Leases | 272.69K | 256.94K | 406.02K | 374.33K | 369.38K | 366.17K |
| Current Unearned Revenue | 6.21M | 8.30M | ||||
| Other Current Liabilities | 13.64M | 6.16M | 301.55K | 2.89M | 147.61K | 138.21K |
| Total Current Liabilities | 20.13M | 12.98M | 14.17M | 16.84M | 13.03M | 18.76M |
| Long-Term Leases | 560.49K | 640.97K | 399.07K | 745.72K | 987.31K | 1.07M |
| Other Long-Term Liabilities | 36.88K | 36.88K | 36.88K | 36.88K | 36.88K | 35.02K |
| Total Liabilities | 20.72M | 13.66M | 14.60M | 17.63M | 14.05M | 19.86M |
| Common Stock | 17.68M | 8.68M | 7.12M | 7.07M | 5.36M | 5.30M |
| Additional Paid-In Capital | 465.34M | 354.98M | 334.93M | 334.21M | 282.55M | 280.31M |
| Retained Earnings | -394.07M | -377.83M | -332.19M | -286.13M | -243.46M | -213.98M |
| Comprehensive Income & Other | 57.23M | 55.73M | 51.56M | 47.43M | 43.89M | 33.64M |
| Shareholders' Equity | 146.18M | 41.56M | 61.42M | 102.58M | 88.35M | 105.28M |
| Total Liabilities & Equity | 166.91M | 55.22M | 76.02M | 120.21M | 102.40M | 125.14M |
| Total Debt | 833.18K | 897.92K | 805.09K | 1.12M | 1.36M | 1.43M |
| Net Cash (Debt) | 157.68M | 45.56M | 54.89M | 97.97M | 15.64M | 24.82M |
| Net Cash Per Share | 1.92 | 0.68 | 0.93 | 1.78 | 0.35 | 0.60 |
| Filing Date Shares Outstanding | 147.37M | 72.29M | 59.35M | 58.88M | 44.70M | 44.20M |
| Total Common Shares Outstanding | 147.37M | 72.29M | 59.35M | 58.88M | 44.70M | 44.20M |
| Working Capital | 145.27M | 40.65M | 57.49M | 92.62M | 84.39M | 76.92M |
| Book Value Per Share | 0.99 | 0.57 | 1.03 | 1.74 | 1.98 | 2.38 |
| Tangible Book Value | 146.11M | 41.53M | 61.41M | 102.54M | 88.21M | 105.05M |
| Tangible Book Value Per Share | 0.99 | 0.57 | 1.03 | 1.74 | 1.97 | 2.38 |
Cash flow statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -39.14M | -45.63M | -46.06M | -42.67M | -29.48M | -45.63M |
| Depreciation & Amortization | 353.98K | 403.52K | 442.93K | 567.78K | 596.60K | 669.43K |
| Other Amortization | 15.96K | 15.96K | 42.19K | |||
| Stock-Based Compensation | 2.39M | 4.44M | 4.07M | 3.41M | 6.04M | 4.33M |
| Other Operating Activities | 5.96M | 599.21K | -4.76M | -131.29K | -1.13M | -846.55K |
| Change in Accounts Receivable | 2.20M | 2.20M | 1.04M | 7.83M | ||
| Change in Inventory | 5.04M | 6.90M | 4.47M | -11.37M | ||
| Change in Accounts Payable | -4.43M | -5.99M | -580.13K | 6.99M | -3.59M | 316.11K |
| Change in Unearned Revenue | -6.21M | -2.09M | 8.30M | |||
| Change in Other Net Operating Assets | 3.91M | 1.75M | -7.21M | 3.77M | -4.10M | -7.08M |
| Operating Cash Flow | -23.71M | -35.31M | -48.56M | -37.81M | -33.74M | -39.94M |
| Capital Expenditures | -135.94K | -115.69K | -46.87K | -81.10K | -162.39K | -37.78K |
| Investment in Securities | 29.61M | 3.35M | 52.41M | -17.62M | 19.52M | -25.91M |
| Other Investing Activities | -1.00 | 1.00 | ||||
| Investing Cash Flow | 29.48M | 3.23M | 52.36M | -17.70M | 19.36M | -25.95M |
| Long-Term Debt Repaid | -357.58K | -388.11K | -373.98K | -364.43K | -360.64K | |
| Lease Payments | -309.21K | -357.58K | -388.11K | -373.98K | -364.43K | -360.64K |
| Net Debt Issued (Repaid) | -309.21K | -357.58K | -388.11K | -373.98K | -364.43K | -360.64K |
| Issuance of Common Stock | 134.31M | 22.90M | 1.10M | 56.72M | 2.35M | 66.16M |
| Other Financing Activities | -8.38M | 10.77M | -323.73K | -3.36M | -47.73K | -4.22M |
| Financing Cash Flow | 125.63M | 33.32M | 386.45K | 52.99M | 1.94M | 61.58M |
| Foreign Exchange Rate Adjustments | 2.17M | -3.59M | 1.41M | -974.10K | 2.46M | 4.59M |
| Miscellaneous Cash Flow Adjustments | 1.00 | |||||
| Net Cash Flow | 133.56M | -2.35M | 5.61M | -3.50M | -9.98M | 281.31K |
| Free Cash Flow | -23.85M | -35.43M | -48.60M | -37.89M | -33.91M | -39.97M |
| Free Cash Flow Margin | -120,793.78% | -29,316.52% | -60,064.46% | |||
| Free Cash Flow Per Share | -0.29 | -0.53 | -0.82 | -0.69 | -0.77 | -0.96 |
| Levered Free Cash Flow | -4.31M | -14.83M | -30.97M | 32.62M | -30.42M | -80.47M |
| Unlevered Free Cash Flow | -4.27M | -14.81M | -30.96M | 32.64M | -30.39M | -80.45M |
| Free Cash Flow After Leases | -24.15M | -35.79M | -48.99M | -38.27M | -34.27M | -40.34M |
| Cash Interest Paid | 56.92K | 34.47K | 21.06K | 36.02K | 44.95K | 23.63K |
| Change in Working Capital | 6.72M | 4.86M | -2.28M | 1.00M | -9.77M | 1.54M |
Ratios
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 260.10M | 68.42M | 145.44M | 95.98M | 137.03M | 210.33M |
| Enterprise Value | 79.96M | 17.18M | 117.22M | 72.98M | 114.99M | 103.23M |
| Last Close Price | 1.66 | 1.01 | 2.47 | 1.63 | 3.10 | 4.76 |
| PS Ratio | 1,986.88 | 847.36 | 1,376.36 | |||
| PB Ratio | 1.46 | 1.40 | 2.29 | 0.85 | 1.45 | 1.76 |
| P/TBV Ratio | 1.50 | 1.40 | 2.29 | 0.85 | 1.45 | 1.76 |
| EV/Sales Ratio | 498.91 | 682.90 | 1,046.48 | |||
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.08 | -1.10 | -0.89 | -0.95 | -0.18 | -0.24 |
| Net Debt / EBITDA Ratio | 4.42 | 0.94 | 1.04 | 1.70 | 0.49 | 0.52 |
| Net Debt / FCF Ratio | 6.61 | 1.29 | 1.13 | 2.58 | 0.46 | 0.62 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | |||
| Inventory Turnover | 0.36 | |||||
| Quick Ratio | 7.95 | 3.69 | 3.85 | 5.58 | 1.42 | 1.47 |
| Current Ratio | 8.22 | 4.13 | 5.06 | 6.50 | 7.48 | 5.10 |
| Return on Equity (ROE) | -38.52% | -88.63% | -56.18% | -44.69% | -30.45% | -49.83% |
| Return on Assets (ROA) | -18.54% | -45.97% | -33.77% | -32.60% | -17.71% | -27.91% |
| Return on Capital Employed (ROCE) | -24.30% | -114.30% | -85.70% | -56.20% | -36.10% | -44.80% |
| Earnings Yield | -30.87% | -78.31% | -32.79% | -49.14% | -22.99% | -24.67% |
| FCF Yield | -10.66% | -60.80% | -34.60% | -43.64% | -26.44% | -21.62% |
| Buyback Yield / Dilution | -31.84% | -14.20% | -7.24% | -24.28% | -6.19% | -53.82% |